Spain · Delayed Price · Currency is EUR Biotechnology Assets Statistics
Total Valuation
BME:BST has a market cap or net worth of EUR 16.79 million. The enterprise value is 17.75 million.
| Market Cap | 16.79M |
| Enterprise Value | 17.75M |
Important Dates
The last earnings date was Tuesday, April 21, 2026.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:BST has 74.29 million shares outstanding. The number of shares has increased by 10.20% in one year.
| Current Share Class | 74.29M |
| Shares Outstanding | 74.29M |
| Shares Change (YoY) | +10.20% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.09% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.89 |
| PB Ratio | 2.41 |
| P/TBV Ratio | 3.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.17 |
| EV / EBITDA | 111.24 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.40 |
| Quick Ratio | 1.40 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 10.22 |
| Debt / FCF | -107.99 |
| Interest Coverage | -5.69 |
Financial Efficiency
Return on equity (ROE) is -28.25% and return on invested capital (ROIC) is -9.68%.
| Return on Equity (ROE) | -28.25% |
| Return on Assets (ROA) | -3.38% |
| Return on Invested Capital (ROIC) | -9.68% |
| Return on Capital Employed (ROCE) | -7.45% |
| Weighted Average Cost of Capital (WACC) | 13.69% |
| Revenue Per Employee | 131,986 |
| Profits Per Employee | -73,695 |
| Employee Count | 30 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:BST has paid 319,968 in taxes.
| Income Tax | 319,968 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.93% in the last 52 weeks. The beta is 1.84, so BME:BST's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | -45.93% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.27 |
| Relative Strength Index (RSI) | 35.22 |
| Average Volume (20 Days) | 80,778 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:BST had revenue of EUR 3.43 million and -1.92 million in losses. Loss per share was -0.03.
| Revenue | 3.43M |
| Gross Profit | 3.17M |
| Operating Income | -766,981 |
| Pretax Income | -1.60M |
| Net Income | -1.92M |
| EBITDA | 159,567 |
| EBIT | -766,981 |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 666,218 in cash and 1.63 million in debt, with a net cash position of -963,807 or -0.01 per share.
| Cash & Cash Equivalents | 666,218 |
| Total Debt | 1.63M |
| Net Cash | -963,807 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 6.96M |
| Book Value Per Share | 0.10 |
| Working Capital | 1.32M |
Cash Flow
In the last 12 months, operating cash flow was -13,110 and capital expenditures -1,984, giving a free cash flow of -15,094.
| Operating Cash Flow | -13,110 |
| Capital Expenditures | -1,984 |
| Depreciation & Amortization | 926,548 |
| Net Borrowing | -1.13M |
| Free Cash Flow | -15,094 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 92.52%, with operating and profit margins of -22.35% and -55.84%.
| Gross Margin | 92.52% |
| Operating Margin | -22.35% |
| Pretax Margin | -46.53% |
| Profit Margin | -55.84% |
| EBITDA Margin | 4.65% |
| EBIT Margin | -22.35% |
| FCF Margin | n/a |
Dividends & Yields
BME:BST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.20% |
| Shareholder Yield | -10.20% |
| Earnings Yield | -11.41% |
| FCF Yield | -0.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:BST has an Altman Z-Score of -7.98 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.98 |
| Piotroski F-Score | 5 |